Profil bibliographique

В. В. Береговых

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

73Publications signalées

138Citations signalées

1Affiliations récentes

Les institutions déclarées

Les domaines associés

Pharmaceutical Economics and PolicyEconomic, Social, and Public Health Issues in Russia and GloballyAnalytical Chemistry and ChromatographyEconomic Sanctions and International RelationsNeurological Disorders and Treatments

Les publications récentes

Accès ouvert 2026 article OpenAlex

Fortelyzin in the treatment of minor acute ischemic stroke according to a subanalysis of the observational study FORPI registry

N. А. Shamalov, M. Yu. Martynov, N. A. Marskaya, Д. Р. Хасанова et autres

ru, us, ua (code pays fourni par la source)

0 citations Neurology neuropsychiatry Psychosomatics

Accès ouvert 2026 article OpenAlex

Fortelyzin in the treatment of acute ischemic stroke due to basilar-artery occlusion: data from the observational study FORPI registry

N. А. Shamalov, M. Yu. Martynov, N. A. Marskaya, Д. Р. Хасанова et autres

ru, us, ua (code pays fourni par la source)

0 citations Neurology neuropsychiatry Psychosomatics

2026 article OpenAlex

Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry

N. А. Shamalov, M.Yu. Martynov, N.A. Marskaya, Д. Р. Хасанова et autres

ru, us (code pays fourni par la source)

2 citations S S Korsakov Journal of Neurology and Psychiatry

2025 article OpenAlex

Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry

N.A. Shamalov, M.Yu. Martynov, E I Gusev, N.A. Marskaya et autres

ru, us, pl, gb, Rwanda, jp, ge, cn (code pays fourni par la source)

4 citations S S Korsakov Journal of Neurology and Psychiatry

Accès ouvert 2025 article OpenAlex

Efficacy and safety profile of apixaban and rivaroxaban in patients with atrial fibrillation and valvular heart disease and the role of drug interactions

О. В. Жукова, N. L. Shimanovsky, В. В. Береговых

0 citations Clinical pharmacology and therapy

2025 article OpenAlex

Risks and limitations of using artificial intelligence in medicine

В. В. Береговых, V I Panteleev, Николай Львович Шимановский, Pavel G. Roitberg

ru (code pays fourni par la source)

0 citations Annals of the Russian academy of medical sciences

Accès ouvert 2025 article OpenAlex

Mesenchymal Stem Cells in Liver Fibrosis: A Dose-Dependent Recovery

A. V. Lyundup, M. Yu. Shagidulin, Н. А. Онищенко, В. В. Береговых et autres

ru (code pays fourni par la source)

2 citations Applied Sciences

2025 article OpenAlex

Pharmaceutical Product Manufacturing Readiness Levels

А.М. Pyatigorsky, G.E. Brkich, В. В. Береговых, N.V. Pyatigorskaya et autres

2 citations Annals of the Russian academy of medical sciences

2025 article OpenAlex

Water soluble peroral pharmaceutical form of phosphatidylcholine: experimental and clinical data in combined hyperlipidemia

С. С. Маркин, В. В. Кухарчук, А.В. Лисица, Е. А. Пономаренко et autres

1 citation Annals of the Russian academy of medical sciences

2025 article OpenAlex

Efficacy and safety of dapagliflozin in the treatment of chronic heart failure

О. В. Жукова, В. В. Береговых, Николай Львович Шимановский

0 citations Annals of the Russian academy of medical sciences

2025 article OpenAlex

Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trial

В. В. Кухарчук, Elena A. Ponomarenko, Andrey Lisitsa, Yu. A. Romashova et autres

ru (code pays fourni par la source)

0 citations Biomeditsinskaya Khimiya

Accès ouvert 2024 article OpenAlex

Methodological foundations of pharmaceutical development of cell-based preparations

A. V. Lyundup, В. В. Береговых

us, ru (code pays fourni par la source)

0 citations Annals of the Russian academy of medical sciences

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.